Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
Clinical trial NCT00019214 · COMPLETED
Trial details
- NCT number
- NCT00019214
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1997-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.